Diagnosis and treatment of type 2 diabetes and other disorders
US7879859B2 · kind B2 · utility
0Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2006 |
| Grant date | Feb 1, 2011 |
| Priority date | — |
| Expiry date | Dec 21, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/042
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application features the use of the somatostatin subtype 3 receptor (SST3) as a target for affecting insulin secretion and for diagnosing diabetes related disorders. Glucose stimulated insulin secretion was found to be stimulated by knocking down expression of SST3 and through the use of a SST3 selective antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.